China Medical System Holdings Limited (FRA:2M7C)
Germany
· Delayed Price · Currency is EUR 1.450
+0.010 (0.69%)
At close: Dec 5, 2025
FRA:2M7C Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,594 | 2,269 | 3,930 | 3,613 | 3,608 | 2,256 | Upgrade
|
| Market Cap Growth | 59.25% | -42.27% | 8.77% | 0.15% | 59.92% | -29.14% | Upgrade
|
| Enterprise Value | 2,980 | 1,621 | 3,341 | 3,146 | 3,323 | 2,101 | Upgrade
|
| Last Close Price | 1.45 | 0.88 | 1.43 | 1.21 | 1.18 | 0.72 | Upgrade
|
| PE Ratio | 18.32 | 10.58 | 12.83 | 8.17 | 8.64 | 7.12 | Upgrade
|
| PS Ratio | 3.85 | 2.30 | 3.84 | 2.91 | 3.13 | 2.59 | Upgrade
|
| PB Ratio | 1.76 | 1.05 | 1.98 | 1.81 | 2.03 | 1.62 | Upgrade
|
| P/TBV Ratio | 2.29 | 1.38 | 2.62 | 2.45 | 2.95 | 2.38 | Upgrade
|
| P/FCF Ratio | 32.98 | 13.87 | 12.44 | 7.54 | 10.55 | 6.79 | Upgrade
|
| P/OCF Ratio | 31.75 | 13.52 | 12.31 | 7.50 | 10.45 | 6.69 | Upgrade
|
| EV/Sales Ratio | 3.13 | 1.64 | 3.27 | 2.53 | 2.88 | 2.42 | Upgrade
|
| EV/EBITDA Ratio | 11.08 | 6.50 | 8.96 | 6.17 | 7.15 | 5.67 | Upgrade
|
| EV/EBIT Ratio | 12.61 | 7.42 | 9.65 | 6.53 | 7.62 | 6.07 | Upgrade
|
| EV/FCF Ratio | 27.35 | 9.91 | 10.58 | 6.56 | 9.72 | 6.32 | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.05 | 0.09 | 0.12 | 0.13 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.39 | 0.45 | 0.45 | 0.48 | 0.51 | 0.20 | Upgrade
|
| Debt / FCF Ratio | 0.82 | 0.70 | 0.53 | 0.51 | 0.69 | 0.23 | Upgrade
|
| Asset Turnover | 0.42 | 0.42 | 0.45 | 0.55 | 0.59 | 0.58 | Upgrade
|
| Inventory Turnover | 3.14 | 2.91 | 3.48 | 4.45 | 4.90 | 4.60 | Upgrade
|
| Quick Ratio | 5.12 | 5.10 | 3.89 | 2.79 | 3.22 | 4.89 | Upgrade
|
| Current Ratio | 5.78 | 5.74 | 4.29 | 3.07 | 3.55 | 5.46 | Upgrade
|
| Return on Equity (ROE) | 9.90% | 10.10% | 15.74% | 23.75% | 25.26% | 24.79% | Upgrade
|
| Return on Assets (ROA) | 5.58% | 5.77% | 9.56% | 13.23% | 13.82% | 14.47% | Upgrade
|
| Return on Capital (ROIC) | 5.91% | 6.04% | 10.14% | 14.27% | 14.99% | 15.74% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.60% | 10.00% | 17.30% | 23.90% | 23.00% | 23.40% | Upgrade
|
| Earnings Yield | 5.46% | 9.45% | 7.79% | 12.24% | 11.58% | 14.04% | Upgrade
|
| FCF Yield | 3.03% | 7.21% | 8.04% | 13.27% | 9.48% | 14.73% | Upgrade
|
| Dividend Yield | 2.29% | 4.04% | 3.51% | 6.00% | 5.75% | 7.18% | Upgrade
|
| Payout Ratio | 40.93% | 34.34% | 56.66% | 39.16% | 38.27% | 32.96% | Upgrade
|
| Buyback Yield / Dilution | 1.13% | 1.00% | 0.08% | 0.56% | 0.17% | 0.34% | Upgrade
|
| Total Shareholder Return | 3.44% | 5.04% | 3.59% | 6.55% | 5.92% | 7.53% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.